Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/13/2006EP0979276B1 Complement receptor type 1 (cr1)-like sequences
12/13/2006EP0973914B1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
12/13/2006EP0968284B1 An improved method for the production and purification of adenoviral vectors
12/13/2006EP0883343B1 Compositions for treating ischemic tissue
12/13/2006EP0875251B1 Therapeutic agent for treatment of fiv infections
12/13/2006EP0854885B1 Recombinant anti-cd4 antibodies for human therapy
12/13/2006EP0809695B1 Transcription factor - e2f-5
12/13/2006EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006EP0651805B1 Method of intracellular binding of target molecules
12/13/2006CN1878871A IL-1 receptor based antagonists and methods of making and using
12/13/2006CN1878867A Recombinant peptide vector comprising the gene for treatment for autoimmune diseases
12/13/2006CN1878791A 合成的抗微生物多肽 Synthetic antimicrobial polypeptides
12/13/2006CN1878789A Human cathelicidin antimicrobial peptides
12/13/2006CN1878570A Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
12/13/2006CN1878565A Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
12/13/2006CN1878564A Glutamine for use in treating injury
12/13/2006CN1878563A Pharmaceutical compositions including low dosages of desmopressin
12/13/2006CN1878562A Antybody therapy
12/13/2006CN1878555A Combination comprising n-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate
12/13/2006CN1878545A Thyroid hormone analogs and methods of use
12/13/2006CN1878541A Microparticles comprising somatostatin analogues
12/13/2006CN1878529A Combined cosmetic or therapeutic preparation
12/13/2006CN1876833A Anti-hiv agent evaluation method
12/13/2006CN1876826A Production and amplification method for recombinant protein medicine by ammonia salt forced fermentation
12/13/2006CN1876825A Enzyme-hydrolyzed polypeptide of ostrich blood and physiological activity thereof
12/13/2006CN1876796A Vigorous wine and preparation method thereof
12/13/2006CN1876684A A series of polypeptide capable of blocking IL-6 and its medicinal uses
12/13/2006CN1876683A Human antibodies that bind human TNFalpha
12/13/2006CN1876682A Transferin (Tf)- nerve growth factor (NGF) conjugate preparation method
12/13/2006CN1876681A Cancer-suppressing protein and its gene and uses
12/13/2006CN1876680A Recombinant solenopsis invicta sensitized toxin protein and its uses
12/13/2006CN1876678A Retroviral resistant polypeptide and its preparing method
12/13/2006CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof
12/13/2006CN1876676A Antineoplastic oligopeptide and its preparation method and application
12/13/2006CN1876186A Endostatin conjugate and its preparation method
12/13/2006CN1876178A Granule with beauty and health function
12/13/2006CN1876177A Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses
12/13/2006CN1876176A Omega-conotoxin M VII A mutant and its preparation and uses
12/13/2006CN1876175A Neurotrophic factor slow release nanometer formulation and its preparation method and uses
12/13/2006CN1876174A Pharmaceutical combination containing kuhseng element and thymus pentapeptide and preparation method thereof
12/13/2006CN1876173A Thymus pentapeptide slow-release microshpere formulation for injection and its preparation method
12/13/2006CN1875992A Enzymolysis peptide of locust and its physiological activity
12/13/2006CN1875988A Method for preparing low molecular weighted glucidamin collagen composition, its product and use
12/13/2006CN1875748A Application method of lactoferritin in food
12/13/2006CN1289678C Production and use of high expression, high purity, high activity gene recombinant human lysozyme
12/13/2006CN1289673C Anemone neurotoxin gene Sr6 and application thereof
12/13/2006CN1289672C Hippocampus protease inhibitor gene and its use
12/13/2006CN1289670C Polynucleotide useful for modulating cancer cell proliferation
12/13/2006CN1289528C Recombinant human interferon-alpha 1b compound and process for preparation
12/13/2006CN1289527C Horny cell growth factor mutant with high bioactivity and its preparation process and use thereof
12/13/2006CN1289526C Stem cell factor
12/13/2006CN1289524C Human telomerase active inhibitor protein and use thereof
12/13/2006CN1289521C Anagonism peptide of tumor necrosis factor and its application
12/13/2006CN1289466C Pharmaceutical compounds
12/13/2006CN1289145C Application of plasminogen in preparing topical pharmaceutical composition for promoting tympanic membrane perforation in mammal
12/13/2006CN1289144C Medicine for treating radioactive membrana mucosa damage, repeative aphtha and paradentitis
12/13/2006CN1289143C Method for reducing decreasing blood-glucose and delaying weight increase of diabetic
12/13/2006CN1289142C Medicinal new dosage form containing SA liposome as medicine carrier
12/13/2006CN1289141C Thrombogenesis inhibiting medicine
12/13/2006CN1289140C Use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine
12/13/2006CN1289098C Vesicular stromatitis virus (VSV)
12/13/2006CN1289082C Medicine composition for treating diabetes
12/13/2006CN1289066C Glicetin -1 slow release microspheric preparation and its use
12/13/2006CN1289061C Medicine for preventing and treating bromidrosis
12/12/2006US7149304 Personal communication center performance display and status alert system
12/12/2006US7148404 Antimicrobial polypeptides
12/12/2006US7148399 Coffee mannanase
12/12/2006US7148378 Analgesics; neuropathic pain; bipolar disorders
12/12/2006US7148359 Protease inhibitors; viricides; purity, crystal structure
12/12/2006US7148346 Feeding the feedstock into an extraction column under conditions adapted for separating more- or less-polar impurities from feedstock, lighter phase flows counter to a heavier phase; product is a cyclosporin, a rapamycin
12/12/2006US7148342 Compositions and methods for sirna inhibition of angiogenesis
12/12/2006US7148338 Comprises nucleotide sequences coding oligopeptidase for use in screening compounds for treatment of cell proliferative and metabolic disorders; enzyme inhibitors
12/12/2006US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006US7148333 Stabilization; administering by injection
12/12/2006US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal
12/12/2006US7148328 Compositions and methods for regulating autolytic processes in bacteria
12/12/2006US7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
12/12/2006US7148322 Process for the preparation of echinocandin derivatives
12/12/2006US7148260 Water-based emulsifier wax gels including free sphingoid bases and oil in-water emulsion including the same
12/12/2006US7148257 Methods of treating mesothelioma with suberoylanilide hydroxamic acid
12/12/2006US7148233 Treatment of cardiovascular and related pathologies
12/12/2006US7148209 Repairing tissues in humans or animals using blood and tissue dependent polymer gels
12/12/2006US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein
12/12/2006US7148201 Use of human plasma hyaluronidase in cancer treatment
12/12/2006US7148199 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
12/12/2006US7148198 Antibacterial agents
12/12/2006US7148197 Orally administered small peptides synergize statin activity
12/12/2006US7148196 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine
12/12/2006US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/12/2006US7148194 peptide agents to prevent and to treat skin-related conditions, such as wrinkles
12/12/2006US7148193 Polypeptides for binding hormone receptors for detection of growth receptors for cattle or humans
12/12/2006US7148192 Neuroprotective dietary supplement
12/12/2006US7148191 Antigenic composition
12/12/2006US7148190 Haptotactic peprides
12/12/2006US7148062 Method for generating primate trophoblasts
12/12/2006US7148050 method of screening for agents which decrease extracellular matrix degradation; test compound which binds to the proteine kinase-like protein polypeptide is thereby identified as a potential agent for decreasing extracellular matrix degradation
12/12/2006US7148048 Elution through a chromatography column, using a hydroxyapatite column; biological injection, treating genetic disorders
12/12/2006US7148044 Nucleic acid enzyme for RNA cleavage
12/12/2006US7148039 Protein derived composition for skin care using spider silk protein or an analog with adjuvants
12/12/2006US7148037 Platelet-derived growth factor D, DNA coding therefor, and uses thereof